Clinical Research Directory
Browse clinical research sites, groups, and studies.
ACURATE neo2™ Post Market Clinical Follow up Study
Sponsor: Boston Scientific Corporation
Summary
The ACURATE Neo2 PMCF is aimed at collecting clinical and device performance outcomes data with the ACURATE neo2™ Transfemoral Aortic Valve System as used in routine clinical practice for the treatment of severe calcific aortic stenosis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2020-12-16
Completion Date
2026-12-31
Last Updated
2025-06-25
Healthy Volunteers
No
Interventions
Transcatheter Aortic Valve Implantation/Replacement
The device is placed in patients heart at the level of aortic valve through a transfemoral access from femoral groin as indicated in device IFU
Locations (19)
Aarhus Universitetshospital
Aarhus, Denmark
Rigshospitalet
Copenhagen, Denmark
Odense University Hospital
Odense, Denmark
Kerckhoff-Klinik GmbH Herz und Thorax Zentrum Abteilung Kardiologie/Kardiochirurgie
Bad Nauheim, Germany
HDZ Bad Oeynhausen
Bad Oeynhausen, Germany
St.-Johannes-Hospital
Dortmund, Germany
Universitätsklinik Regensburg
Regensburg, Germany
A.O.U Policlinico "G.Rodolico - San Marco"
Catania, CA, Italy
San Raffaele Hospital
Milan, Italy
Azienda Ospedaliera Pisana
Pisa, Italy
Erasmus Medical Center
Rotterdam, Netherlands
UMC Utrecht
Utrecht, Netherlands
Hospital Clinico de Santiago
Santiago de Compostela, Spain
Hospital Clinico Universitario Valladolid
Valladolid, Spain
Lund University, Cardiology department
Lund, Sweden
Karolinska Universitetssjukhuset
Stockholm, Sweden
Universitätsspital Zürich
Zurich, Switzerland
Liverpool Heart and Chest Hospital
Liverpool, United Kingdom
John Radcliffe Hospital
Oxford, United Kingdom